Neihulizumab, CAS 2158362-38-8

Product Description: Neihulizumab (ALTB-168) is an immune checkpoint agonistic antibody that binds to human CD162 (PSGL-1), leading to downregulation of activated T-cells. Neihulizumab can be uesd for steroid-refractory acute graft-versus-host-disease (SR-aGVHD), psoriasis, psoriatic arthritis and ulcerative colitis research[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Sameem Abedin, et al. Experimental Pharmaceuticals for Steroid-Refractory Acute Graft-versus-Host Disease. J Exp Pharmacol. 2020 Nov 26;12:549-557./[2]Sameem Abedin, et al. Neihulizumab (ALTB-168) in Patients with Steroid-Refractory Acute Graft-Versus-Host-Disease (SR-aGVHD) or Treatment-Refractory Acute Graft-Versus-Host-Disease (TR-aGVHD). Blood (2022) 140 (Supplement 1): 10495-10497.

CAS Number: 2158362-38-8

Molecular Weight: N/A

Compound Purity: 98.10

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Apoptosis

• Artikelnummer: MEXHY-P99378-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99378-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK